Cabot (NYSE:CBT) Releases FY 2027 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY 2027 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 6.150-6.750 for the period, compared to the consensus estimate of 7.030.

Cabot Trading Down 4.9%

Shares of CBT opened at $72.00 on Wednesday. Cabot has a 1-year low of $58.33 and a 1-year high of $94.53. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The firm has a 50 day simple moving average of $77.55 and a 200-day simple moving average of $79.52. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 17.96, a price-to-earnings-growth ratio of 8.91 and a beta of 0.83.

Cabot (NYSE:CBT) last issued its earnings results on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.06. Cabot had a net margin of 5.69% and a return on equity of 19.79%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $927.29 million. During the same quarter in the prior year, the business posted $1.70 EPS. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. Equities analysts forecast that Cabot will post 7.08 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on CBT shares. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, October 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. Truist Financial set a $100.00 target price on shares of Cabot in a report on Wednesday, August 5th. Finally, UBS Group cut their price objective on Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Cabot has a consensus rating of “Hold” and an average target price of $87.80.

Insider Transactions at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the business’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the sale, the chief executive officer owned 404,134 shares of the company’s stock, valued at approximately $34,351,390. The trade was a 25.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have sold 229,597 shares of company stock valued at $19,646,746. Corporate insiders own 3.08% of the company’s stock.

Cabot News Roundup

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Fourth-quarter adjusted EPS of $1.61 topped the $1.55 consensus, while revenue of $1.01 billion exceeded estimates of about $927 million and grew 12.2% year over year. Cabot beats Q4 earnings and revenue estimates
• Positive Sentiment: Cabot reported $43 million in fiscal-year EBITDA from Battery Materials and secured a $50 million U.S. Department of Energy grant to expand domestic production of battery conductive additives. It also returned capital through dividends and share repurchases during fiscal 2026. Cabot fiscal 2026 results
• Neutral Sentiment: Cabot plans $200 million to $230 million in fiscal 2027 capital spending, indicating continued investment but also substantial cash needs. Cabot fiscal 2027 outlook and capital spending
• Negative Sentiment: Fiscal 2027 adjusted EPS guidance of $6.15–$6.75 falls short of the $7.03 analyst consensus, raising concerns about the company’s near-term earnings outlook. The quarterly adjusted EPS result also declined from $1.70 a year earlier, and coverage cited weaker margins despite the estimate beat. Cabot falls despite beating estimates on weaker margins

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.